Recipharm’s new blow-fill-seal machinery is now operational following a substantial investment last year at its facility in Kaysersberg, France. 

The ‎€18 million investment added a new blow-fill-seal, high-speed filling, and packaging line to the site, upping the total number of lines to eight and increasing the facility’s manufacturing capacity by 200 million unidoses per year. 

In addition, the investment adds 2,400 square meters to the facility, creating space for three more machines, which will ultimately allow the site to manufacture over 1.2 billion unidoses per year.

Yves Buelens, general manager at Recipharm’s Kaysersberg site, said, “Recipharm has only owned the facility for two years and during that time have taken some very fast and positive decisions to invest in Kaysersberg. We have worked hard to develop a flexible service that can cater for even the most complex of projects. Adding the line to our facility will allow us to take on new customer projects more quickly, as well as continue to meet our current customers’ requirements. The additional space we’ve added also means we are also well positioned for further growth in line with future customer demand.”

The Kaysersberg site specializes in blow-fill-seal technology for sterile liquids. The site manufactures single dose units and has an advanced aseptic process for sterile liquid packaging applications.